Research output per year
Research output per year
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Bone Marrow Mesenchymal Stromal Cell-mediated Resistance in Multiple Myeloma against NK Cells can be Overcome by Introduction of CD38-CAR or TRAIL-variant
Holthof, L. C., Stikvoort, A., van der Horst, H. J., Gelderloos, A. T., Poels, R., Li, F., Groen, R. W. J., Zweegman, S., van de Donk, N. W. C. J., O'Dwyer, M. & Mutis, T., May 2021, In: HemaSphere. 5, 5, p. e561Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Bone marrow mesenchymal stromal cells can render multiple myeloma cells resistant to cytotoxic machinery of CAR T cells through inhibition of apoptosis
Holthof, L. C., van der Schans, J. J., Katsarou, A., Poels, R., Gelderloos, A. T., Drent, E., van Hal-van Veen, S. E., Li, F., Zweegman, S., van de Donk, N. W. C. J., Themeli, M., Groen, R. W. J. & Mutis, T., 1 Jul 2021, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 27, 13, p. 3793-3803 11 p.Research output: Contribution to journal › Article › Academic › peer-review
-
CD38-specific chimeric antigen receptor expressing natural killer KHYG-1 cells: A proof of concept for an "Off the Shelf" therapy for multiple myeloma
Stikvoort, A., van der Schans, J., Sarkar, S., Poels, R., Ruiter, R., Naik, J., Yuan, H., de Bruijn, J. D., van de Donk, N. W. C. J., Zweegman, S., Themeli, M., Groen, R., O'Dwyer, M. & Mutis, T., Jul 2021, In: HemaSphere. e596.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumab
Casneuf, T., Adams, H. C., van de Donk, N. W. C. J., Abraham, Y., Bald, J., Vanhoof, G., Van der Borght, K., Smets, T., Foulk, B., Nielsen, K. C., Rusbuldt, J., Axel, A., Lysaght, A., Ceulemans, H., Stevenaert, F., Usmani, S. Z., Plesner, T., Avet-Loiseau, H., Nijhof, I., Mutis, T. & 3 others, , Feb 2021, In: Leukemia. 35, 2, p. 573-584 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment
van der Horst, H. J., de Jonge, A. V., Hiemstra, I. H., Gelderloos, A. T., Berry, D. R. A. I., Hijmering, N. J., van Essen, H. F., de Jong, D., Chamuleau, M. E. D., Zweegman, S., Breij, E. C. W., Roemer, M. G. M. & Mutis, T., 1 Feb 2021, In: Blood cancer journal. 11, 2, 38.Research output: Contribution to journal › Article › Academic › peer-review
Open Access